Board Meetings for ASTRAZEN
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ASTRAZEN | AstraZeneca Pharma India Limited | 05 Feb 2018 | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2017. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 06 Nov 2017 | Results/Others | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2017. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 08 Aug 2017 | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 09 May 2017 | Results | inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2017. Further that the 'Trading Window' shall remain closed for all Designated Persons, from March 16, 2017 to May 11, 2017 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 02 Feb 2017 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2016. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 11 Nov 2016 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2016. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 09 Aug 2016 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2016. Company would also like to inform that the Trading Window shall remain closed for all Designated Persons, from June 16, 2016 to August 11, 2016 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 25 May 2016 | Results/Others | Inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2016. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 06 Feb 2016 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2015. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 06 Nov 2015 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2015. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 04 Aug 2015 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2015. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 27 May 2015 | Results | Inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and the year ended March 31, 2015. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 11 Feb 2015 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2014. | |
| ASTRAZEN | AstraZeneca Pharma India Limited | 03 Nov 2014 | Results | inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2014. Further the 'Trading Window' shall remain closed for all Specified Persons, from October 16, 2014 to November 4, 2014 (both days inclusive) in terms of Company - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992. | - |
| ASTRAZEN | AstraZeneca Pharma India Limited | 12 Aug 2014 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2014. The 'Trading Window' shall remain closed for all Specified Persons, from August 1, 2014 to August 13, 2014 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Preventiion of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider trading) Regulations, 1992. | - |